Detalles de la búsqueda
1.
Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: the role of rectal artesunate.
Malar J
; 17(1): 380, 2018 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30348157
2.
Training Community Health Workers to Manage Uncomplicated and Severe Malaria: Experience From 3 Rural Malaria-Endemic Areas in Sub-Saharan Africa.
Clin Infect Dis
; 63(suppl 5): S264-S269, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941103
3.
Compliance With Malaria Rapid Diagnostic Testing by Community Health Workers in 3 Malaria-Endemic Countries of Sub-Saharan Africa: An Observational Study.
Clin Infect Dis
; 63(suppl 5): S276-S282, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941105
4.
Malaria Rapid Diagnostic Tests and Malaria Microscopy for Guiding Malaria Treatment of Uncomplicated Fevers in Nigeria and Prereferral Cases in 3 African Countries.
Clin Infect Dis
; 63(suppl 5): S290-S297, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941107
5.
Feasibility of Malaria Diagnosis and Management in Burkina Faso, Nigeria, and Uganda: A Community-Based Observational Study.
Clin Infect Dis
; 63(suppl 5): S245-S255, 2016 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27941101
6.
Beyond command and control: A rapid review of meaningful community-engaged responses to COVID-19.
Glob Public Health
; 16(8-9): 1439-1453, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33734007
7.
Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study.
Ther Clin Risk Manag
; 17: 1187-1198, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34815671
8.
Peoples' attitude toward COVID-19 vaccine, acceptance, and social trust among African and Middle East countries.
Health Promot Perspect
; 11(2): 171-178, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34195040
9.
Immunogenicity and Safety of 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Administered to Children With Sickle Cell Disease Between 8 Weeks and 2 Years of Age: A Phase III, Open, Controlled Study.
Pediatr Infect Dis J
; 36(5): e136-e150, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28403055
Resultados
1 -
9
de 9
1
Próxima >
>>